This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Aspenbio Pharma, Inc.. Active years: 2009-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2013
Title: The Innovations of Richard G. Donnelly
Introduction
Richard G. Donnelly is a notable inventor based in Fort Collins, Colorado. He has made significant contributions to the fields of reproductive biology and medical diagnostics. With a total of 4 patents, his work has advanced the understanding and treatment of various conditions.
Latest Patents
Donnelly's latest patents include innovative methods for inducing superovulation in ungulates. This invention provides methods for producing biologically active recombinant bFSH and increasing reproduction in mammals, particularly in cattle. The recombinant bFSH developed by Donnelly enhances superovulation, embryo development, and reproductive efficiency in ungulates. Another significant patent focuses on methods and devices for diagnosing appendicitis. This method involves identifying symptoms of appendicitis and detecting specific molecules associated with the condition in patient samples. The devices and kits designed for these assays include a flow-through immunoassay format for testing blood samples.
Career Highlights
Donnelly is currently associated with AspenBio Pharma, Inc., where he continues to innovate in the field of biotechnology. His work has been instrumental in developing solutions that address critical health issues.
Collaborations
Donnelly has collaborated with notable colleagues such as Mark Colgin and John F. Bealer, contributing to a dynamic research environment that fosters innovation.
Conclusion
Richard G. Donnelly's contributions to science and technology through his patents reflect his commitment to improving health outcomes. His work in reproductive biology and medical diagnostics continues to have a lasting impact.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile